IVD Industry Knowledge Of HACCP Inspections, Bayesian Statistics Key
This article was originally published in The Gray Sheet
Executive SummaryIn vitro diagnostics manufacturers need to become more familiar with Hazard Analysis and Critical Control Points (HACCP) and the use of Bayesian statistical methods in clinical trials, according to Health Industry Manufacturers Association's Director of Technology and Regulatory Affairs Carolyn Jones.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.